Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Settings
XBI [NYSE]
SPDR S&P Biotech ETF
Index- P/E- EPS (ttm)- Insider Own- Shs Outstand- Perf Week3.47%
Market Cap- Forward P/E- EPS next Y- Insider Trans- Shs Float- Perf Month8.99%
Income- PEG- EPS next Q- Inst Own- Short Float- Perf Quarter26.28%
Sales- P/S- EPS this Y- Inst Trans- Short Ratio- Perf Half Y-2.15%
Book/sh- P/B- EPS next Y- ROA- Target Price- Perf Year36.09%
Cash/sh- P/C- EPS next 5Y- ROE- 52W Range112.49 - 171.46 Perf YTD25.14%
Dividend1.20 P/FCF- EPS past 5Y- ROI- 52W High-5.55% Beta-
Dividend %0.74% Quick Ratio- Sales past 5Y- Gross Margin- 52W Low43.96% ATR4.28
Employees- Current Ratio- Sales Q/Q- Oper. Margin- RSI (14)63.01 Volatility2.09% 2.34%
OptionableYes Debt/Eq- EPS Q/Q- Profit Margin- Rel Volume0.25 Prev Close159.84
ShortableYes LT Debt/Eq- Earnings- Payout- Avg Volume464.40K Price161.95
Recom- SMA207.35% SMA508.27% SMA20015.07% Volume114,844 Change1.32%
26-Aug-14 01:25PM  After Recent Surge, Are Biotech ETFs Back on Track? Zacks +6.03%
07:00AM  Biotech Stock Boom Times Are Back at TheStreet
25-Aug-14 01:54PM  InterMune Deal Boosts Biotech-ETFs at Barrons.com
21-Aug-14 02:44PM  The Real Divergence is Within Small-Caps Yahoo Finance Blogs
06:00AM  This one stock sector can withstand all the bubble talk at MarketWatch
18-Aug-14 04:00PM  SPDR┬« S&P Biotech ETF Receives Settlement Payment Business Wire
12-Aug-14 10:12AM  Intercept Soars, and That's Good for Fidelity Investors at Barrons.com
07:00AM  Grading Janet Yellen's social media bubble call at CNBC
31-Jul-14 04:10PM  With a 2% Thud, Stocks End Worst Month Since January at Barrons.com
04:10PM  With a 2% Thud, Stocks End Worst Month Since January, Dow Negative in 2014 at Barrons.com
29-Jul-14 10:07AM  4 Biotech ETFs Beating S&P 500 ETF.com
09:08AM  Margin Debt Cycle: Not Dead Yet? Yahoo Finance Blogs
25-Jul-14 10:01AM  Forecast Part II: Sell S&P 500 Passive Interests - This Market Is For Stock Pickers at Seeking Alpha
24-Jul-14 05:41PM  Dynamic And Durable Growth (Part 1) at Seeking Alpha
09:05AM  Earnings Beats Drive ETFs; LinkedIn Boosts Social Media ETF Benzinga
23-Jul-14 11:45AM  Puma Pumps up Biotech ETFs ETF Trends +6.86%
11:19AM  Today's Market: Biotech Names Rallying Today at Seeking Alpha
21-Jul-14 01:52PM  Your Best Wealth-Building Choice From Today's Top Market-Maker Price Range Forecasts at Seeking Alpha
18-Jul-14 10:44AM  ISI Biotech Analyst to Janet Yellen: What Bubble? at Barrons.com
07:51AM  Biotech Stock Mailbag: AcelRx, Yellen Aftermath, Nymox at TheStreet
16-Jul-14 02:22PM  Sector Spotlight: iShares Nasdaq Biotech $IBB-Preliminary Support @ 244-245 Yahoo Finance Blogs
01:08PM  Which Matters More: Janet Yellen Or Earnings & Economic Data? Benzinga
09:20AM  Daily State Of The Markets: Which Matters More: Yellen Or Earnings/Econ Data? at Seeking Alpha
15-Jul-14 06:19PM  Cramer: Janet Yellen saying short Yelp? at CNBC
12:07PM  Johnson & Johnson Earnings Good News For Gilead Sciences at Barrons.com
11:23AM  Fed Disses Social Media, Biotech (Again): Hawkish Policy in Disguise? at Barrons.com
09-Jul-14 02:19PM  6 Signs The Momentum Meltdown May Have Resumed Benzinga
08:21AM  Daily State Of The Markets: Has The Momentum Meltdown Resumed? at Seeking Alpha
08-Jul-14 05:46PM  [video] Biotech buys right now at CNBC
10:36AM  March Redux? Once-Hot ETFs Lead Tuesday Selloff at Barrons.com
02-Jul-14 05:21PM  3 American ETFs That Saw Fireworks to Start 2014 Zacks
01-Jul-14 12:23PM  Confronting Health Care ETF ValuationsAgain ETF Trends
24-Jun-14 11:36AM  Vertex Lifts These Biotech ETFs
10:49AM  Vertex Pharmaceuticals: Hard to Find a Bear at Barrons.com
10:49AM  Vertex Pharmaceuticals: Hard to Find a Bear
23-Jun-14 08:00AM  Aging stinks, so at least make some money from it at CNBC
08:00AM  Aging stinks, so at least make some money from it
19-Jun-14 07:38PM  Genesiss Williams Calls Biotech an Opportunity (Audio) at Bloomberg
07:38PM  Genesiss Williams Calls Biotech an Opportunity (Audio)
18-Jun-14 01:35PM  How Will Biotechnology ETFs Finish Out the Year? Zacks
01:35PM  How Will Biotechnology ETFs Finish Out the Year?
13-Jun-14 05:05PM  Buyout Cycle Boosts Biotech ETFs at Seeking Alpha
05:05PM  Buyout Cycle Boosts Biotech ETFs
11-Jun-14 06:52PM  Biotech ETFs Bounce Back After Three-Month Correction at Investor's Business Daily
06:52PM  Biotech ETFs Bounce Back After Three-Month Correction
06:45PM  Biotech Stocks Get Turbo Boost From Idenix Deal at Seeking Alpha
06:45PM  Biotech Stocks Get Turbo Boost From Idenix Deal
10:30AM  A Super Semiconductor ETF ETF Trends
10:30AM  A Super Semiconductor ETF
10-Jun-14 09:02AM  Two Biotech ETFs Surge on Idenix-Merck Deal Zacks
09:02AM  Two Biotech ETFs Surge on Idenix-Merck Deal
09-Jun-14 04:02PM  Short ETFs Are Often A Dangerous Delusion - Unless You Want To Short Them at Seeking Alpha +6.16%
04:02PM  Short ETFs Are Often A Dangerous Delusion - Unless You Want To Short Them
02:25PM  Like That Idenix Deal? Owners of These ETFs Do at Barrons.com
02:25PM  Like That Idenix Deal? Owners of These ETFs Do
12:09PM  Why These Two Biotech ETFs Are Soaring Monday ETF Trends
12:09PM  Why These Two Biotech ETFs Are Soaring Monday
11:51AM  Portfolio Managers Almost Unanimously Negative on Biotech Stocks at Minyanville
06-Jun-14 01:28PM  A Stable ETF to Gain Exposure to a Volatile Biotech Sector ETF Trends
07:00AM  Eventual 'QE' For The Euro-Zone? Consider European Index ETFs at Seeking Alpha
07:00AM  Eventual 'QE' For The Eurozone? Consider European Index ETFs at Seeking Alpha
04-Jun-14 09:37AM  Best ETFs: QQQ And The Sector Funds at Forbes
09:37AM  Best ETFs: QQQ and the Sector Funds at Forbes
03-Jun-14 12:52AM  Index ETFs May Not Track Benchmarks as Expected at The Wall Street Journal
12:17AM  Index ETFs May Not Track Benchmarks as Expected at The Wall Street Journal
02-Jun-14 11:01PM  Index ETFs May Not Track Benchmarks as Expected at The Wall Street Journal
09:00PM  Index ETFs May Not Track Benchmarks as Expected at The Wall Street Journal
05:22PM  Index ETFs May Not Track Benchmarks as Expected at The Wall Street Journal
30-May-14 02:14PM  Celgene: Why There's Upside at Barrons.com
29-May-14 12:42PM  A Comprehensive Guide to Biotech ETFs Zacks
27-May-14 03:23PM  Can The Bull Market Survive A Momentum Meltdown? Benzinga
22-May-14 10:00AM  Celgene Gains on 'Curious' Management Changes at Barrons.com
21-May-14 01:44PM  ETF Best Buys Today, On A Wealth-Builder's Value Scale at Seeking Alpha
19-May-14 01:59PM  Stock market midday: Steady as she goes at CNBC
15-May-14 06:13PM  The Great ETF Rotation Is Accelerating at Seeking Alpha
13-May-14 10:58AM  What's Hurting Biotechnology Stocks? at Seeking Alpha
12-May-14 02:19PM  Will The S&P See A Large Decline In The Short-Term? Benzinga
11:59AM  Stock market rally holds up; traders wonder why at CNBC
09-May-14 01:12PM  Gilead Sciences' Sovaldi Still Selling; Biogen's Tecfidera Launch 'Going Well' at Barrons.com
11:31AM  The two big question marks facing traders at CNBC
09:38AM  [video] Small cap correction underway at CNBC
08-May-14 03:49PM  Citi: Regeneron a Buy, Will Regenerate at Barrons.com
07-May-14 05:55AM  Growth Story: Fund Managers Buy Healthcare at Seeking Alpha
06-May-14 02:27PM  ETFs See $1.5B In Inflows Last Week; Shorting Junk Bonds, Biotech Just Got Pricier at Barrons.com
12:46PM  More Upside Possible for Biotech ETF ETF Trends
05-May-14 12:29PM  6 Charts That Help Explain What's Been Happening In The Momentum Names Lately Benzinga
09:15AM  Biotech: a More Encouraging Chart at Barrons.com
02-May-14 07:31AM  Will Novel Treatment Innovations Continue to Drive Biotech Sector Success Stories? A Wall Street Transcript Interview with Brian Skorney, Senior Analyst with Robert W. Baird & Co. Wall Street Transcript
01-May-14 10:54AM  Best-in-Class HDAC Inhibitor Creates Selected Stock Catalyst: A Wall Street Transcript Interview with David Nierengarten, Ph.D., an Analyst at Wedbush Securities Covering the Biotechnology, Biopharmaceuticals and Biodefense Sector Wall Street Transcript
29-Apr-14 09:32AM  It's Already Biotech's Third-Worst Selloff at Barrons.com
08:25AM  Daily State Of The Markets: 10 Bear Market Catalysts To Watch For at Seeking Alpha
28-Apr-14 01:06PM  A Wall Street Transcript Interview with Boris Peaker, Ph.D., Executive Director and Senior Analyst with Oppenheimer & Co. Covering the Biotechnology Sector: Strong Outlook for Orphan and Oncology Treatments Wall Street Transcript
26-Apr-14 08:30AM  Biotech: The Poster Child for Market Volatility in 2014 at 24/7 Wall St.
08:30AM  Biotech: The Poster Child for Market Volatility in 2014 24/7 Wall St.
25-Apr-14 03:16PM  Amid Biotech Selloff, Celgene Gets an Upgrade; Gilead's Nine-Day Win Streak at Risk at Barrons.com
24-Apr-14 02:23PM  Alexion Pharmaceuticals: How to Buck a Biotech Selloff at Barrons.com
10:29AM  Biotech Falls Again as Celgene Suffers at Barrons.com
23-Apr-14 12:21PM  Gilead Sciences: "Officially a Value Stock" at Barrons.com
22-Apr-14 03:18PM  Biotech ETFs Gain Ahead of Earnings at Barrons.com
21-Apr-14 03:22PM  Sarepta Therapeutics: How Much Hinges on Approval? at Barrons.com
The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of an index derived from the biotechnology segment of a U.S. total market composite index. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology industry group of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.